{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:40:07Z","timestamp":1746391207528,"version":"3.40.4"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Children with hemophilia frequently require long-term central venous access devices (CVADs) for regular infusion of factor products. Hemophilia patients are not immunocompromised, but the presence and use of CVADs are associated with infections including bacteremia. Currently, the utility of blood cultures in evaluation of the febrile hemophilia patient with an indwelling CVAD is unknown, nor is optimal empiric antibiotic use.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective cross-sectional study of febrile immunocompetent hemophilia patients with CVADs presenting to a large academic urban pediatric emergency department from 1995 to 2017. We used a natural language processing electronic search, followed by manual chart review to construct the cohort. We analyzed rate of pathogen recovery from cultures of blood in subgroups of hemophilia patients, the pathogen profile, and the reported pathogen susceptibilities to ceftriaxone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Natural language processing electronic search identified 181 visits for fever among hemophilia patients with indwelling CVADs of which 147 cases from 44 unique patients met study criteria. Cultures of blood were positive in 56 (38%) of 147 patients (95% confidence interval, 30%\u201347%). Seventeen different organisms were isolated (10 pathogens and 7 possible pathogens) with <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic> and coagulase-negative <jats:italic toggle=\"yes\">Staphylococcus<\/jats:italic> species as the most common. Thirty-four percent of isolates were reported as susceptible to ceftriaxone. Positive blood cultures were more common in cases involving patients with inhibitors (n = 71) versus those without (n = 76), odds ratio, 7.4 (95% confidence interval, 3.5\u201315.9). This was observed irrespective of hemophilia type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Febrile immunocompetent hemophilia patients with indwelling CVADs have high rates of bacteremia. Empiric antimicrobial therapy should be targeted to anticipated pathogens and take into consideration local susceptibility patterns for <jats:italic toggle=\"yes\">Staphylococcus aureus.<\/jats:italic>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000002106","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T20:34:19Z","timestamp":1588192459000},"page":"e1531-e1534","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Utility of Blood Cultures and Empiric Antibiotics in Febrile Pediatric Hemophilia Patients With Central Venous Access Devices"],"prefix":"10.1097","volume":"37","author":[{"given":"Hanny","family":"Al-Samkari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al","family":"Ozonoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assaf","family":"Landschaft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rotem","family":"Kimia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marvin B.","family":"Harper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy E.","family":"Croteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir A.","family":"Kimia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,4,29]]},"reference":[{"key":"bib1-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2516.2004.00943.x","article-title":"Consensus recommendations for use of central venous access devices in haemophilia","volume":"10","year":"2004","journal-title":"Haemophilia"},{"key":"bib2-20250504","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1365-2516.2007.01605.x","article-title":"Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience","volume":"14","year":"2008","journal-title":"Haemophilia"},{"key":"bib3-20250504","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2141.1995.tb05270.x","article-title":"Use of central venous catheters in children with severe congenital coagulopathy","volume":"91","year":"1995","journal-title":"Br J Haematol"},{"key":"bib4-20250504","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2516.2003.00840.x","article-title":"Central venous access devices in haemophilia","volume":"10","year":"2004","journal-title":"Haemophilia"},{"key":"bib5-20250504","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2141.2007.06703.x","article-title":"The risk associated with indwelling catheters in children with haemophilia","volume":"138","year":"2007","journal-title":"Br J Haematol"},{"key":"bib7-20250504","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/PEC.0000000000000484","article-title":"An introduction to natural language processing: how you can get more from those electronic notes you are generating","volume":"31","year":"2015","journal-title":"Pediatr Emerg Care"},{"key":"bib8-20250504","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia a with inhibitors","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"bib9-20250504","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia A without inhibitors","volume":"379","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"bib10-20250504","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.25153","article-title":"Shifting landscape of hemophilia therapy: implications for current clinical laboratory coagulation assays","volume":"93","year":"2018","journal-title":"Am J Hematol"},{"key":"bib11-20250504","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1538-7836.2004.00653.x","article-title":"A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia","volume":"2","year":"2004","journal-title":"J Thromb Haemost"},{"key":"bib12-20250504","first-page":"254","article-title":"Evaluation of fever in infants and young children","volume":"87","year":"2013","journal-title":"Am Fam Physician"},{"key":"bib13-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0000000000001849","article-title":"Clinical characteristics and risk factors of long-term central venous catheter-associated bloodstream infections in children","volume":"37","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"bib14-20250504","first-page":"1","article-title":"CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children","volume":"20","year":"2016","journal-title":"Health Technol Assess"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:04:09Z","timestamp":1746389049000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,29]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000002106","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"type":"electronic","value":"1535-1815"},{"type":"print","value":"0749-5161"}],"subject":[],"published":{"date-parts":[[2020,4,29]]}}}